Beyond Air Up 11%, Insiders Still Down After US$3.05m Purchase [Yahoo! Finance]
Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
Beyond Air, Inc. (NASDAQ: XAIR) had its price target lowered by analysts at Truist Financial Co. from $10.00 to $8.00. They now have a "buy" rating on the stock.